Engineering mycobacteria for vaccination and controlled human infection studies

Global Tuberculosis Report 2024 (World Health Organization, 2024); https://www.who.int/publications/i/item/9789240101531

Mangtani, P. et al. Clin. Infect. Dis. 58, 470–480 (2014).

Article  PubMed  Google Scholar 

Darrah, P. A. et al. Nature 577, 95–102 (2020).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jackson, S. & McShane, H. in Human Challenge Studies for Vaccine Development (eds Bagnoli, F. et al.) 229–255 (Current Topics in Microbiology and Immunology, Vol. 445) (Springer, 2024).

Morrison, H., Jackson, S. & McShane, H. Front. Immunol. 14, 1211388 (2023).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kleinwaks, G., Schmit, V. & Morrison, J. Vaccine 40, 173–174 (2022).

Article  PubMed  Google Scholar 

Blazevic, A., Xia, M., Turan, A., Tennant, J. & Hoft, D. F. Tuberculosis 105, 108–112 (2017).

Article  PubMed  Google Scholar 

Davids, M. et al. Am. J. Respir. Crit. Care Med. 201, 1277–1291 (2020).

Article  CAS  PubMed  Google Scholar 

Wang, X. et al. Nat. Microbiol. https://doi.org/10.1038/s41564-024-01913-5 (2025).

Article  PubMed  PubMed Central  Google Scholar 

Smith, A. A. et al. Nat. Microbiol. https://doi.org/10.1038/s41564-024-01895-4 (2025).

Article  PubMed  Google Scholar 

Lenis, A. T., Lec, P. M. & Chamie, K. JAMA 324, 1980–1991 (2020).

Article  CAS  PubMed  Google Scholar 

留言 (0)

沒有登入
gif